Shinozaki E - Search Results

1

ASO Author Reflections: The Role of CEA Optimizing Perioperative Treatments for Colorectal Cancer with Liver Metastases.

Yoshino K, Osumi H, Ito H, Yamaguchi K, Shinozaki E. Yoshino K, et al. Among authors: shinozaki e. Ann Surg Oncol. 2022 Dec;29(13):8394-8395. doi: 10.1245/s10434-022-12372-9. Epub 2022 Aug 6. Ann Surg Oncol. 2022. PMID: 35933537 No abstract available.

2

Simultaneous identification of 36 mutations in KRAS codons 61 and 146, BRAF, NRAS, and PIK3CA in a single reaction by multiplex assay kit.

Bando H, Yoshino T, Shinozaki E, Nishina T, Yamazaki K, Yamaguchi K, Yuki S, Kajiura S, Fujii S, Yamanaka T, Tsuchihara K, Ohtsu A. Bando H, et al. Among authors: shinozaki e. BMC Cancer. 2013 Sep 3;13:405. doi: 10.1186/1471-2407-13-405. BMC Cancer. 2013. PMID: 24006859 Free PMC article.

3

[Three cases of fatal thrombocytopenia after oxaliplatin-based chemotherapy].

Osumi H, Shinozaki E, Kumekawa Y, Ogura M, Ozaka M, Suenaga M, Matsusaka S, Chin K, Mizunuma N, Yokoyama M. Osumi H, et al. Among authors: shinozaki e. Gan To Kagaku Ryoho. 2013 Nov;40(11):1557-60. Gan To Kagaku Ryoho. 2013. PMID: 24231715 Japanese.

4

Acquired drug resistance conferred by a KRAS gene mutation following the administration of cetuximab: a case report.

Osumi H, Matsusaka S, Shinozaki E, Suenaga M, Mingyon M, Saiura A, Ueno M, Mizunuma N, Yamaguchi T. Osumi H, et al. Among authors: shinozaki e. BMC Res Notes. 2013 Dec 5;6:508. doi: 10.1186/1756-0500-6-508. BMC Res Notes. 2013. PMID: 24304820 Free PMC article.

5

Chemotherapy is effective for stage I gastric cancer in patients with synchronous esophageal cancer.

Osumi H, Yoshio T, Chin K, Ogura M, Kumekawa Y, Suenaga M, Matsusaka S, Shinozaki E, Miyamoto Y, Morishige K, Ishiyama A, Hirasawa T, Tsuchida T, Yamamoto Y, Fujisaki J, Igarashi M, Mizunuma N. Osumi H, et al. Among authors: shinozaki e. Gastric Cancer. 2016 Apr;19(2):625-630. doi: 10.1007/s10120-015-0517-9. Epub 2015 Aug 11. Gastric Cancer. 2016. PMID: 26260873 Clinical Trial.

6

Associations between deepness of response and clinical outcomes among Japanese patients with metastatic colorectal cancer treated with second-line FOLFIRI plus cetuximab.

Osumi H, Matsusaka S, Suenaga M, Shinozaki E, Mizunuma N. Osumi H, et al. Among authors: shinozaki e. Onco Targets Ther. 2015 Aug 6;8:2005-13. doi: 10.2147/OTT.S87101. eCollection 2015. Onco Targets Ther. 2015. PMID: 26273206 Free PMC article.

7

Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chemotherapy?

Osumi H, Shinozaki E, Suenaga M, Kumekawa Y, Ogura M, Ozaka M, Matsusaka S, Chin K, Yamamoto N, Mizunuma N. Osumi H, et al. Among authors: shinozaki e. BMC Cancer. 2015 Oct 21;15:760. doi: 10.1186/s12885-015-1751-6. BMC Cancer. 2015. PMID: 26490659 Free PMC article.

8

Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival.

Osumi H, Shinozaki E, Osako M, Kawazoe Y, Oba M, Misaka T, Goto T, Kamo H, Suenaga M, Kumekawa Y, Ogura M, Ozaka M, Matsusaka S, Chin K, Hatake K, Mizunuma N. Osumi H, et al. Among authors: shinozaki e. Mol Clin Oncol. 2015 Sep;3(5):1053-1057. doi: 10.3892/mco.2015.602. Epub 2015 Jul 9. Mol Clin Oncol. 2015. PMID: 26623049 Free PMC article.

9

RAS mutation is a prognostic biomarker in colorectal cancer patients with metastasectomy.

Osumi H, Shinozaki E, Suenaga M, Matsusaka S, Konishi T, Akiyoshi T, Fujimoto Y, Nagayama S, Fukunaga Y, Ueno M, Mise Y, Ishizawa T, Inoue Y, Takahashi Y, Saiura A, Uehara H, Mun M, Okumura S, Mizunuma N, Miki Y, Yamaguchi T. Osumi H, et al. Among authors: shinozaki e. Int J Cancer. 2016 Aug 15;139(4):803-11. doi: 10.1002/ijc.30106. Epub 2016 Apr 19. Int J Cancer. 2016. PMID: 27004837 Free article.

10

Serum VEGF-A and CCL5 levels as candidate biomarkers for efficacy and toxicity of regorafenib in patients with metastatic colorectal cancer.

Suenaga M, Mashima T, Kawata N, Wakatsuki T, Horiike Y, Matsusaka S, Dan S, Shinozaki E, Seimiya H, Mizunuma N, Yamaguchi K, Yamaguchi T. Suenaga M, et al. Among authors: shinozaki e. Oncotarget. 2016 Jun 7;7(23):34811-23. doi: 10.18632/oncotarget.9187. Oncotarget. 2016. PMID: 27166185 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page